A Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat Accumulation

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

China

Peking Union Medical College Hospital, Beijing, Beijing Municipality

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi